Bay Colony Advisory Group, Inc D Gilead Sciences, Inc. Transaction History
Bay Colony Advisory Group, Inc D
- $643 Million
- Q4 2024
A detailed history of Bay Colony Advisory Group, Inc D transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 3,863 shares of GILD stock, worth $409,323. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,863
Previous 3,842
0.55%
Holding current value
$409,323
Previous $322,000
10.56%
% of portfolio
0.06%
Previous 0.05%
Shares
25 transactions
Others Institutions Holding GILD
# of Institutions
2,045Shares Held
1BCall Options Held
10MPut Options Held
9.05M-
Black Rock Inc. New York, NY121MShares$12.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.2 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.6 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.4 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.14 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $133B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...